RxDoctor Payments Data

Troyanna Egan, PA

Physician Assistant · State College, PANPI 1558143370

Payments from drug & device makers

$2,339in general payments, 2019–2025

Across 120 payments — averaging $19.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$675
  • Endo USA, Inc.$317
  • AstraZeneca$238
  • Johnson & Johnson$215
  • Ferring Pharmaceuticals Inc.$201
  • AbbVie$152
  • plus $542 from 8 others

What the payments were for

  • Food & beverage$2,339100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,339 in reported general payments places this provider in the 85th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$26,505
Medicare patients
201
Services billed
689

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron79$62,146
MyrbetriqMirabegron37$33,214
Mirabegron ErMirabegron16$9,611
PremarinEstrogens, Conjugated14$6,911
Methenamine Hippurate67$3,937
Tamsulosin Hcl326$3,697
Solifenacin Succinate79$2,998
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst207$2,021
Finasteride150$1,778
Dutasteride37$1,563
Alfuzosin Hcl ErAlfuzosin Hcl49$954
Oxybutynin Chloride ErOxybutynin Chloride36$903
NitrofurantoinNitrofurantoin Macrocrystal16$483
Ciprofloxacin Hcl72$250
Ondansetron OdtOndansetron17$177

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$675$62,14679 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in State College

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →